PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 26, 2026Pediatric Blood & Cancer0 citations

Somatic PLCG1 Mutation in a Vascular Tumor of an Infant

View Full Paper
GHGrace HeslinUniversity of CambridgeSLSarah M. LeiterUniversity of CambridgeSSShahab ShahipasandCambridge University Hospitals NHS Foundation Trust

Key Points

  • To explore the presence of somatic mutations in the PLCG1 gene in an infant's vascular tumor.
  • Case report analysis focusing on the genetic mutation present in the tumor.
  • Sample included a vascular tumor from an infant, with no new datasets generated.
  • Identified a somatic PLCG1 mutation in the vascular tumor.
  • Findings may have implications for understanding genetic factors in vascular tumors.

Abstract

Data Sharing not applicable to this article, as no new datasets were generated or analyzed during the current study.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Heslin et al. (2026) studied this question.

synapsesocial.com/papers/69edacbd4a46254e215b46d0https://doi.org/10.1002/1545-5017.70357
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1KDR Activating Mutations in Human Angiosarcomas Are Sensitive to Specific Kinase Inhibitors2009 · 274 citations
  2. 2Consistent MYC and FLT4 gene amplification in radiation‐induced angiosarcoma but not in other radiation‐associated atypical vascular lesions2010 · 351 citations
  3. 3A Recurrent Activating PLCG1 Mutation in Cardiac Angiosarcomas Increases Apoptosis Resistance and Invasiveness of Endothelial Cells2014 · 77 citations
  4. 4Recurrent CIC Gene Abnormalities in Angiosarcomas2016 · 208 citations
  5. 5MEK inhibitors in cancer treatment: structural insights, regulation, recent advances and future perspectives2023 · 81 citations